全文获取类型
收费全文 | 383261篇 |
免费 | 25100篇 |
国内免费 | 2818篇 |
专业分类
耳鼻咽喉 | 5307篇 |
儿科学 | 8239篇 |
妇产科学 | 10139篇 |
基础医学 | 53675篇 |
口腔科学 | 11867篇 |
临床医学 | 30452篇 |
内科学 | 79544篇 |
皮肤病学 | 8673篇 |
神经病学 | 27472篇 |
特种医学 | 14261篇 |
外国民族医学 | 82篇 |
外科学 | 61372篇 |
综合类 | 9980篇 |
现状与发展 | 1篇 |
一般理论 | 64篇 |
预防医学 | 17607篇 |
眼科学 | 9484篇 |
药学 | 31339篇 |
1篇 | |
中国医学 | 2223篇 |
肿瘤学 | 29397篇 |
出版年
2021年 | 2688篇 |
2019年 | 2794篇 |
2018年 | 4609篇 |
2017年 | 3507篇 |
2016年 | 3619篇 |
2015年 | 4114篇 |
2014年 | 5814篇 |
2013年 | 7524篇 |
2012年 | 10274篇 |
2011年 | 10469篇 |
2010年 | 6337篇 |
2009年 | 5996篇 |
2008年 | 9710篇 |
2007年 | 10543篇 |
2006年 | 10482篇 |
2005年 | 9546篇 |
2004年 | 9025篇 |
2003年 | 8771篇 |
2002年 | 8398篇 |
2001年 | 28416篇 |
2000年 | 28934篇 |
1999年 | 23820篇 |
1998年 | 5226篇 |
1997年 | 4284篇 |
1996年 | 3872篇 |
1995年 | 3516篇 |
1994年 | 3133篇 |
1993年 | 2873篇 |
1992年 | 16142篇 |
1991年 | 14896篇 |
1990年 | 14236篇 |
1989年 | 14031篇 |
1988年 | 12651篇 |
1987年 | 12126篇 |
1986年 | 11178篇 |
1985年 | 10383篇 |
1984年 | 6958篇 |
1983年 | 5632篇 |
1982年 | 2725篇 |
1979年 | 5499篇 |
1978年 | 3362篇 |
1977年 | 2990篇 |
1975年 | 2658篇 |
1974年 | 3080篇 |
1973年 | 2880篇 |
1972年 | 2841篇 |
1971年 | 2798篇 |
1970年 | 2525篇 |
1969年 | 2560篇 |
1968年 | 2272篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
31.
32.
33.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献
34.
Prevention Science - This study aimed to evaluate the effectiveness of the drug and violence resistance educational program (PROERD) on short-term secondary outcomes, such as intentions to use... 相似文献
35.
Shimon Kurasawa Takahiro Imaizumi Shoichi Maruyama Keitaro Tanaka Yoko Kubo Mako Nagayoshi Hiroaki Ikezaki Sadao Suzuki Teruhide Koyama Chihaya Koriyama Aya Kadota Sakurako Katsuura-Kamano Kiyonori Kuriki Kenji Wakai Keitaro Matsuo 《International journal of cancer. Journal international du cancer》2023,153(4):732-741
The association between kidney function and cancer incidence is inconsistent among previous reports, and data on the Japanese population are lacking. It is unknown whether kidney function modifies the cancer risk of other factors. We aimed to evaluate the association of estimated glomerular filtration rate (eGFR) with cancer incidence and mortality in 55 242 participants (median age, 57 years; 55% women) from the Japan Multi-Institutional Collaborative Cohort Study. We also investigated differences in cancer risk factors between individuals with and without kidney dysfunction. During a median 9.3-year follow-up period, 4278 (7.7%) subjects developed cancer. Moderately low and high eGFRs were associated with higher cancer incidence; compared with eGFR of 60-74 ml/min/1.73 m2, the adjusted hazard ratios (HRs) (95% confidence intervals [CIs]) for eGFRs of ≥90, 75-89, 45-59, 30-44 and 10-29 ml/min/1.73 m2 were 1.18 (1.07-1.29), 1.09 (1.01-1.17), 0.93 (0.83-1.04), 1.36 (1.00-1.84) and 1.12 (0.55-2.26), respectively. High eGFR was associated with higher cancer mortality, while low eGFR was not; the adjusted subdistribution HRs (95% CIs) for eGFRs of ≥90 and 75-89 ml/min/1.73 m2 were 1.58 (1.29-1.94) and 1.27 (1.08-1.50), respectively. Subgroup analyses of participants with eGFRs ≥60 and <60 ml/min/1.73 m2 revealed elevated cancer risks of smoking and family history of cancer in those with eGFR <60 ml/min/1.73 m2, with significant interactions. Our findings suggest that the relationship between eGFR and cancer incidence was U-shaped. Only high eGFR was associated with cancer mortality. Kidney dysfunction enhanced cancer risk from smoking. 相似文献
36.
37.
38.
39.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis
下载免费PDF全文
![点击此处可从《Transfusion medicine (Oxford, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
40.